Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
November 14, 2022
Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting
November 14, 2022
Rallybio Announces Pricing of $50 Million Public Offering
November 10, 2022
Rallybio Announces Proposed Public Offering
November 8, 2022
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
November 7, 2022
CinCor Pharma Announces Publication in the New England Journal of Medicine of Phase 2 BrigHtn Data on Selective Aldosterone Synthase Inhibitor Baxdrostat in Treatment-Resistant Hypertension
November 7, 2022
CinCor Pharma Appoints Michael W. Kalb, Executive Vice President and Chief Financial Officer
November 7, 2022
Pear Therapeutics Presents Real-world Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe
November 7, 2022
Nouscom’s Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors
November 7, 2022
Leading Fertility Company TMRW Life Sciences Receives FDA 510(k) Clearance for Next-Generation Technology to Safely Manage and Store Frozen Eggs and Embryos
November 7, 2022
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
« Previous Page
1
2
3
4
5
6
…
17
Next Page »